影响急诊医生在创伤患者快速序贯插管中选择肌松剂的围插管因素
该回顾性研究在1级创伤中心纳入215例接受快速序贯插管的成人创伤患者,其中148例使用琥珀胆碱、67例使用罗库溴铵。聚类分析显示,围插管生命体征以异常为主且早期死亡率较高的患者集群更常接受罗库溴铵(74%),而无插管前异常生命体征或早期死亡的患者集群仅24%接受罗库溴铵。逻辑回归显示,插管前低氧血症(aOR 12.3 [2.5-60.9])和使用视频喉镜(aOR 5.5 [1.2-24.6])与选择罗库溴铵相关。作者结论认为,罗库溴铵更常用于围插管生命体征以异常为主且急诊早期死亡率较高的患者集群。
要点
- 插管前低氧血症与急诊医生选择罗库溴铵而非琥珀胆碱相关(aOR 12.3 [2.5-60.9])。
- 使用视频喉镜与选择罗库溴铵相关(aOR 5.5 [1.2-24.6])。
- 围插管生命体征以异常为主且早期死亡率较高的患者集群中74%接受罗库溴铵,而无异常生命体征或早期死亡的患者集群中仅24%接受罗库溴铵。
- 两组年龄、培训水平、平均GCS(10 vs. 10)和中位ISS(27 vs. 27)相似。
- 该研究为单中心回顾性分析,共纳入215例成人创伤快速序贯插管患者(琥珀胆碱148例,罗库溴铵67例)。
适用人群与场景
- 在1级创伤中心急诊科接受快速序贯插管的成人创伤患者,共215例(琥珀胆碱组148例,罗库溴铵组67例)。
研究设计与关键结果
- 研究类型为回顾性研究,在1级创伤中心纳入215例成人创伤快速序贯插管患者,琥珀胆碱组148例、罗库溴铵组67例。
- 两组年龄、培训水平、平均GCS(10 vs. 10)和中位ISS(27 vs. 27)相似。
- 聚类分析显示,围插管生命体征以异常为主且早期死亡率较高的患者集群中74%接受罗库溴铵,而无插管前异常生命体征或早期死亡的患者集群中仅24%接受罗库溴铵。
- 插管前低氧血症与选择罗库溴铵相关(aOR 12.3 [2.5-60.9])。
- 使用视频喉镜与选择罗库溴铵相关(aOR 5.5 [1.2-24.6])。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,罗库溴铵更常用于围插管生命体征以异常为主且急诊早期死亡率较高的患者集群;罗库溴铵的使用与插管前低氧血症和视频喉镜相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: No study has assessed predictors of physician choice between the succinylcholine (Succ) and rocuronium (Roc) for rapid sequence intubation (RSI) during the initial resuscitation of trauma patients in the emergency department (ED).
METHODS: We retrospectively evaluated of the use of Succ and Roc for adult trauma patients undergoing RSI at a Level 1 trauma center. The primary outcome was to identify factors affecting physician choice of paralytic agent for RSI analyzed by cluster analysis using pre-intubation vital signs and early mortality. The secondary outcome was to identify factors influencing physician choice of paralytic agent using a logistic regression model reported as adjusted odds ratios (aOR).
RESULTS: The analysis included 215 patients, including 148 receiving Succ and 67 receiving Roc. The two groups were similar in regard to age, provider level of training, mean GCS (10 vs. 10) and median ISS (27 vs. 27). Cluster analysis using peri-intubation patient vital signs and early mortality indicates that patients with predominantly abnormal vital signs and early mortality were more likely to receive Roc (74%) than those without abnormal vital signs prior to intubation or early mortality (24%). Hypoxemia prior to RSI (aOR 12.3 [2.5-60.9]) and the use of video laryngoscopy (VL) (aOR 5.5 [1.2-24.6]) were associated with the choice to use Roc.
CONCLUSIONS: Roc was more frequently chosen for paralysis in the patient cluster with predominantly abnormal peri-intubation vital signs and higher rate of early ED mortality. The use of Roc was associated with hypoxemia prior to RSI and VL.
参考来源
- West JR, Lott C, Donner L, et al. Peri-intubation factors affecting emergency physician choice of paralytic agent for rapid sequence intubation of trauma patients. Am J Emerg Med. 2017. PMID: 29162438. doi:10.1016/j.ajem.2017.11.038
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。